Occupational Therapists in Hudson, NH Accepting Medicare
7 Occupational Therapists found. Showing 1 - 7
 Ms. Cheryl Elaine Mcguire, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 Lowell Rd, Hudson, NH 03051 Phone: 603-882-5261 |
 Ross Robert Watson, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 Lowell Rd, Hudson, NH 03051 Phone: 603-882-5261 |
Mary Conant, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 203 Lowell Rd, Hudson, NH 03051 Phone: 603-816-8161 |
Elizabeth Mary Friedrich, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 Lowell Rd, Hudson, NH 03051 Phone: 603-882-5261 |
Ms. Cyhtnia Susan Doherty, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5 George St, Hudson, NH 03051 Phone: 603-579-3607 Fax: 603-579-3607 |
Mrs. Clara Bragg, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 Lowell Rd, Hudson, NH 03051 Phone: 603-882-5261 |
Jody Montgomery, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Derry Rd, Hudson, NH 03051 Phone: 603-598-0729 |
News Archive
Americans on a sodium high: CDC report
A new study by federal government researchers shows that most Americans consume too much sodium, and new strategies and stronger efforts are needed to reduce the amount of dietary salt. Experts add that high levels of sodium consumption are associated with increased risk of high blood pressure, which can lead to heart disease and stroke.
Study reveals weakness of pharmacies' clinical decision support software in evaluating drug-drug interactions
A study conducted at the University of Arizona College of Pharmacy found that only 28 percent of pharmacies' clinical decision support software systems - the computer programs that are in place to alert pharmacists to possible medication problems - correctly identified potentially dangerous drug-drug interactions.
Pfizer to present data on hematology portfolio at ASH Annual Meeting
Pfizer said today that new data on investigational compounds in its hematology portfolio will be presented at the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, December 4-7.
Research underscores importance of health behaviors and management in spinal cord injury patients
It can happen in a split second from a vehicle crash, a fall or a gunshot: a person's spinal cord tissue is bruised or torn by a shocking blow.
Cyclacel opens enrollment of sapacitabine Phase 3 trial for AML
Cyclacel Pharmaceuticals, Inc., today announced that it has opened enrollment of the SEAMLESS pivotal Phase 3 trial for the Company's sapacitabine oral capsules as a front-line treatment of elderly patients aged 70 years or older with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive induction chemotherapy.
› Verified 7 days ago
Physical Therapists
Chiropractors
Speech-Language Pathologists
Occupational Therapists
Optometrists